A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis

被引:7
|
作者
Suarez, Miguel [1 ,2 ]
Martinez, Raquel [1 ]
Torres, Ana Maria [2 ]
Torres, Beatriz [3 ]
Mateo, Jorge [2 ]
机构
[1] Virgen Luz Hosp, Gastroenterol Dept, Ave Hermandad Donantes Sangre 1, Cuenca 16002, Spain
[2] Univ Castilla La Mancha, Inst Technol, Med Anal Expert Grp, Cuenca, Spain
[3] Obispo Polanco Hosp, Teruel, Spain
关键词
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Liver fibrosis; Machine learning; DISEASE; CLASSIFICATION; PREVALENCE;
D O I
10.1007/s10620-023-08031-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimNonalcoholic fatty liver disease (NAFLD) is a silent epidemy that has become the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is an advanced stage of NAFLD, which is linked to a high risk of cirrhosis and hepatocellular carcinoma. The aim of this study is to develop a predictive model to identify the main risk factors associated with the progression of hepatic fibrosis in patients with NASH.MethodsA database from a multicenter retrospective cross-sectional study was analyzed. A total of 215 patients with NASH biopsy-proven diagnosed were collected. NAFLD Activity Score and Kleiner scoring system were used to diagnose and staging these patients. Noninvasive tests (NITs) scores were added to identify which one were more reliable for follow-up and to avoid biopsy. For analysis, different Machine Learning methods were implemented, being the eXtreme Gradient Booster (XGB) system the proposed algorithm to develop the predictive model.ResultsThe most important variable in this predictive model was High-density lipoprotein (HDL) cholesterol, followed by systemic arterial hypertension and triglycerides (TG). NAFLD Fibrosis Score (NFS) was the most reliable NIT. As for the proposed method, XGB obtained higher results than the second method, K-Nearest Neighbors, in terms of accuracy (95.05 vs. 90.42) and Area Under the Curve (0.95 vs. 0.91).ConclusionsHDL cholesterol, systemic arterial hypertension, and TG were the most important risk factors for liver fibrosis progression in NASH patients. NFS is recommended for monitoring and decision making.
引用
收藏
页码:3801 / 3809
页数:9
相关论文
共 50 条
  • [21] The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis
    Sharma, Mithun
    Mitnala, Shasikala
    Vishnubhotla, Ravi K.
    Mukherjee, Rathin
    Reddy, Duvvur N.
    Rao, Padaki N.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 (02) : 147 - 158
  • [22] A simple method for inducing nonalcoholic steatohepatitis with fibrosis
    Leyla Yahaghi
    Azadeh Ebrahim-Habibi
    Nasim Hayati-Roodbari
    Shiva Irani
    Parichehreh Yaghmaei
    AnimalModelsandExperimentalMedicine, 2019, 2 (04) : 282 - 290
  • [23] A simple method for inducing nonalcoholic steatohepatitis with fibrosis
    Yahaghi, Leyla
    Ebrahim-Habibi, Azadeh
    Hayati-Roodbari, Nasim
    Irani, Shiva
    Yaghmaei, Parichehreh
    ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2019, 2 (04) : 282 - 290
  • [24] Comparison of risk factors for nonalcoholic steatohepatitis and advanced fibrosis between patients with obese and non-obese nonalcoholic fatty liver disease
    Kim, W.
    Joo, S. K.
    Kim, D.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S597 - S597
  • [25] Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation
    Tokodai, Kazuaki
    Karadagi, Ahmad
    Kjaernet, Felicia
    Romano, Antonio
    Ericzon, Bo-Goran
    Nowak, Greg
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (02) : 233 - 239
  • [26] Nonalcoholic steatohepatitis: risk factors and diagnosis
    Adams, Leon A.
    Feldstein, Ariel E.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (05) : 623 - 635
  • [27] Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
    Dixon, JB
    Bhathal, PS
    O'Brien, PE
    GASTROENTEROLOGY, 2001, 121 (01) : 91 - 100
  • [28] Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Amjad, Waseem
    Shalaurova, Irina
    Garcia, Erwin
    Gruppen, Eke G.
    Dullaart, Robin P. F.
    DePaoli, Alex M.
    Jiang, Z. Gordon
    Lai, Michelle
    Connelly, Margery A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [29] Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis
    Sharma, Sachin
    Le Guillou, Dounia
    Chen, Jennifer Y.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (10) : 662 - 678
  • [30] Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
    Cai, Bishuang
    Dongiovanni, Paola
    Corey, Kathleen E.
    Wang, Xiaobo
    Shmarakov, Igor O.
    Zheng, Ze
    Kasikara, Canan
    Davra, Viralkumar
    Meroni, Marica
    Chung, Raymond T.
    Rothlin, Carla V.
    Schwabe, Robert F.
    Blaner, William S.
    Birge, Raymond B.
    Valenti, Luca
    Tabas, Ira
    CELL METABOLISM, 2020, 31 (02) : 406 - +